Singular Health has signed a non-binding MOU to build and operate a medical imaging repository for Florida Medicaid, with approximately A$3.5 million of potential revenue subject to definitive agreements and delivery. The project could give its 3DICOM platform a state-funded infrastructure reference site, but recurring funding remains unassured.
- Approximately A$3.5m potential FY27 revenue share
- US$3.0m Florida state appropriation to FIU
- Repository designed to reduce duplicate imaging
- Definitive agreements and milestones remain outstanding
- Future annual funding is not guaranteed
Florida Appropriation Creates A$3.5m Revenue Opportunity
Singular Health Group Limited (ASX:SHG) has secured a potentially material step up in scale: an amended and restated memorandum of understanding with Florida International University to design, deliver and operate a medical imaging repository for Florida’s Medicaid program. The project is backed by a US$3.0 million state appropriation, of which Singular Health expects to receive about 85%, or approximately US$2.55 million (around A$3.5 million).
That figure is more than twice Singular Health’s A$1.43 million FY26 revenue and roughly three times the annual value of its largest existing customer agreement, according to the company. Revenue is expected to be recognised during FY27 as the repository is delivered, with payments tied to milestones and the full amount scheduled to be paid by 30 June 2027 or earlier, subject to the final agreements and successful delivery.
Non-Binding MOU Leaves Key Commercial Steps Ahead
The headline opportunity is not yet a binding contract. The MOU commits the parties to enter definitive agreements based on minimum terms, but other terms still need to be agreed, including statements of work, milestones and payment arrangements. Singular Health’s share would be paid to its wholly owned US subsidiary and would not be shared with its PNS joint venture.
The appropriation itself is single-year funding for the 2026-27 financial year and lapses if unspent by 30 June 2027. That creates a clear execution window for a project that must move through infrastructure design, security architecture, data integration, regulatory and privacy approvals, pilot selection, and clinical and economic validation.
Pilot Will Test Duplicate Imaging Savings
The repository is intended to give authorised providers serving Florida Medicaid beneficiaries a common point to locate, access, view and share imaging held across participating organisations. The initial work will focus on a defined pilot population rather than all of Florida’s approximately 3.4 million Medicaid enrollees.
The third phase is designed to measure clinical, operational and economic outcomes, including whether improved access to prior scans reduces unnecessary repeat imaging and associated costs. The underlying data will belong to the State of Florida, while Singular Health expects to use the resulting success metrics when approaching health plans and other state programs. That evidence is central to the company’s proposed savings-share model, but the announcement does not provide a guaranteed savings figure or commercial conversion beyond the initial project.
State Infrastructure Model Expands 3DICOM’s Ambition
Until now, Singular Health’s US commercial model has primarily involved annual per-physician licences for provider networks. The Florida project would be the first proposed deployment of 3DICOM as state-funded infrastructure, while Singular Health retains ownership of its platform intellectual property, including 3DICOM, its repository technology, Gateway, MFTP and workflows.
The arrangement includes a five-year exclusivity framework for Singular Health’s Florida Medicaid projects involving FIU. It does not restrict commercial or non-Medicaid work in Florida, nor projects outside the state. FIU and Singular Health intend to seek comparable or potentially larger annual funding after the initial deployment, but that prospect depends on implementation, measured outcomes, future state budgets and regulatory approvals.
Bottom Line?
The opportunity is large relative to Singular Health’s current revenue, but its investment case now turns on signing the definitive agreements and converting a state-funded pilot into demonstrated, repeatable outcomes.
Questions in the middle?
- When will the definitive agreements and milestone schedule be executed?
- Can the pilot demonstrate a measurable reduction in duplicate imaging and related costs?
- Will Florida approve recurring repository funding after the initial appropriation expires?